Phase modulation spectroscopic system

Claim 2

A spectroscopic method for detecting at least one pathophysiological change in a subject, comprising the steps: (a) introducing into the subject, at an input port, first and second electromagnetic signals of wavelengths sensitive to hemoglobin oxygenation, said signals being modulated by a carrier waveform of frequency on the order of 10 8 hz; (b) measuring the phase shift of said first and second electromagnetic signals that have migrated in the subject from said input to a detection port and (c) determining, on the basis of said relative phase shifts of said signal that have migrated in the subject said pathophysiological change in the subject.

Claim 3

The method recited in claim 1, wherein said pathophysiological change is a change in ionic homeostasis.

Claim 4

The method recited in claim 1, wherein the wavelength of said first electromagnetic signal is in the range of 754 to 60 nm.

Claim 5

The method recited in claim 1, wherein the wavelength of said second electromagnetic signal is in the range of 816 to 840 nm.

Claim 6

The method recited in claim 1, wherein the subject is a human.

Claim 7

The method recited in claim 1, wherein said pathophysiological change is a change in blood flow.

Claim 8

The method recited in claim 6, further comprising the step of detecting an early warning of ischemic brain damage.

Claim 9

The method recited in claim 1, wherein said pathophysiological change is a change in tissue oxygen concentration.

Claim 10

The method as recited in claim 8, further comprising the step of detecting an early warning of hypoxic brain damage.

Claim 11

The method recited in claim 1, further comprising the step of, prior to step (c), correlating said phase shifts to hemoglobin oxygenation in the subject.

Claim 12

The method recited in claim 10, further comprising the step of correlating hemoglobin oxygenation in the subject to an intracellular event.

Claim 13

The method recited in claim 11, wherein said intracellular event includes a reduction of NAD+.

Claim 14

The method recited in claim 11, wherein said intracellular event includes a loss of electrical activity.

Claim 15

The method recited in claim 1, wherein said introducing and measuring steps comprise: (a) generating a first carrier waveform at a first frequency of at least 200 MHz using first oscillator means; (b) generating a second carrier waveform at a second frequency using second oscillator means, said second frequency being offset approximately 25 KHz from said first frequency; (c) generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths sensitive to hemoglobin oxygenation; (d) coupling said two electromagnetic signals of said selected wavelengths to the subject; (e) detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals of said selected wavelengths, said altered signals having been phase-shifted during migration in the subject; and (f) measuring said phase shift of said two electromagnetic signals migrated in the subject.

Claim 16

The method recited in claim 1 or 14 wherein said determining step comprises (a) calculating an effective optical pathlength of photon migrating in said subject; and (b) correlating said pathlength to physiological properties of tissue of said subject through which said photons migrate.

Claim 17

A spectroscopic method for analyzing a scattering medium comprising at least one absorptive constituent, comprising: (a) generating a first carrier waveform at a first frequency of at least 200 MHz; (b) generating a second carrier waveform at a second frequency, said second frequency being offset on the order of 25 KHz from said first frequency; (c) generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths; (d) coupling said two electromagnetic signals of said selected wavelengths to the scattering medium; (e) detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals, said altered signals having been phase-shifted during migration in the scattering medium; (f) generating a reference signal having a frequency approximately equal to the difference between said first and second frequencies; (g) generating, at each said wavelength, a difference signal indicative of the phase-shift that is characteristic of said medium; and (h) determining, on the basis of said phase-shifts, selected property of the subject.

Claim 18

A spectroscopic method for analyzing a scattering medium comprising at least one absorptive constituent, comprising: (a) generating a first carrier waveform at a first frequency of at least 200 MHz; (b) generating a second carrier waveform at a second frequency, said second frequency being offset on the order of 25 KHz from said first frequency; (c) generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths; (d) coupling said two electromagnetic signals of said selected wavelengths to the scattering medium; (e) detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals, said altered signals having been phase-shifted during migration in the scattering medium; (f) generating a reference signal having a frequency approximately equal to the difference between said first and second frequencies; (g) generating, at each said wavelength, a difference signal indicative of the phase-shift that is characteristic of said medium; and (h) determining, on the basis of said phase-shifts, selected property of the subject.

Claim 19

The method recited in claim 16, wherein the absorptive constituent is deoxy-hemoglobin.

Claim 20

The method recited in claim 16, wherein the absorptive constituent is oxy-hemoglobin.

Claim 21

The method recited in claim 16, further comprising the step of correlating the difference signal to hemoglobin oxygenation of the scattering medium.

Claim 22

The method recited in claim 19, wherein the scattering medium comprises a living tissue, and further comprising the step of correlating the hemoglobin oxygenation of the tissue to an intracellular event.

Claim 23

A phase modulation spectroscopic system for detecting at least one pathophysiological change in a subject, comprising: (a) means for introducing into the subject, at an input port, first and second electromagnetic signal of wavelengths sensitive to hemoglobin oxygenation, said signals being modulated by a carrier waveform of frequency on the order of at least 10 8 Hz; (b) means for measuring the phase shift of said first and second electromagnetic signals that have migrated in the subject; and (c) means for determining, on the basis of said relative phase shifts of said signals that have migrated in the subject, said pathophysiological change in the subject.

Claim 24

A phase modulation spectroscopic system for detecting at least one pathophysiological change in a subject, comprising: (a) means for introducing into the subject, at an input port, first and second electromagnetic signal of wavelengths sensitive to hemoglobin oxygenation, said signals being modulated by a carrier waveform of frequency on the order of at least 10 8 Hz; (b) means for measuring the phase shift of said first and second electromagnetic signals that have migrated in the subject; and (c) means for determining, on the basis of said relative phase shifts of said signals that have migrated in the subject, said pathophysiological change in the subject.

Claim 25

The system recited in claim 21, wherein the subject is a human.

Claim 26

The system recited in claim 21, further comprising means for correlating said phase shifts to hemoglobin oxygenation in the subject, and providing a signal indicative of said hemoglobin oxygenation.

Claim 27

The system recited in claim 23, further comprising the means for correlating hemoglobin oxygenation in the subject to an intracellular event, and providing a signal indicative of said intracellular event.

Claim 28

The system recited in claim 24, wherein said intracellular event includes a reduction of NAD+.

Claim 29

The system recited in claim 24, wherein said intracellular event includes a loss of electrical activity.

Claim 30

A phase modulation spectroscopic system for analyzing a scattering medium comprising at least one absorptive constituent, comprising: (a) first oscillator means for generating a first carrier waveform at a first frequency of at least 200 MHz; (b) second oscillator means for generating a second carrier waveform at a second frequency offset on the order of 25 KHz from said first frequency; (c) light source means coupled to said first oscillator means, for generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths; (d) means for coupling said two electromagnetic signals of said selected wavelengths to the scattering medium; (e) detector means for detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals, said altered signals having been phase-shifted during migration in the scattering medium; (f) mixer means, coupled to said first and second oscillator means, for generating a reference signal having a frequency approximately equal to the difference between said first and second frequencies; (g) phase detector means for alternatively generating, at each wavelength, a difference signal indicative of of the phase shift that is characteristic of said medium; and (h) means for determining, on the basis of said phase-shifts, selected property of the subject.

Claim 31

A phase modulation spectroscopic system for analyzing a scattering medium comprising at least one absorptive constituent, comprising: (a) first oscillator means for generating a first carrier waveform at a first frequency of at least 200 MHz; (b) second oscillator means for generating a second carrier waveform at a second frequency offset on the order of 25 KHz from said first frequency; (c) light source means coupled to said first oscillator means, for generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths; (d) means for coupling said two electromagnetic signals of said selected wavelengths to the scattering medium; (e) detector means for detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals, said altered signals having been phase-shifted during migration in the scattering medium; (f) mixer means, coupled to said first and second oscillator means, for generating a reference signal having a frequency approximately equal to the difference between said first and second frequencies; (g) phase detector means for alternatively generating, at each wavelength, a difference signal indicative of of the phase shift that is characteristic of said medium; and (h) means for determining, on the basis of said phase-shifts, selected property of the subject.

Claim 32

The system recited in claim 27, wherein said phase detector means comprises a 74HC221 integrated circuit and a Schmitt trigger circuit for producing a square wave output signal.

Claim 33

The system recited in claim 27, wherein said detector means comprises a heterodyne modulation and mixing network having a resonant circuit providing a load approximately 20,000 ohms at 25 KHz.

Claim 34

The system recited in claim 27, further comprising automatic gain control means for stabilizing the amplitudes of said altered waveforms received from said detector means, said stabilized waveforms coupled to said phase detector means wherein said relative phases are determined.

Claim 35

The system recited in claim 30, wherein said automatic gain control means comprises an MC1350 integrated circuit coupled to a feedback network.

Claim 36

A spectroscopic method of examination of a subject, the subject lying between an optical input port and an optical detection port of a spectroscopic system, the optical pathlength of photons migrating between said ports being determined by the scattering and absorptive properties of the particular subject, the method comprising the steps of: (a) introducing into the subject at the input port at least one electromagnetic signal of selected wavelength, the signal having been modulated by a carrier waveform of frequency that enables determination of said pathlength; (b) detecting the signal at the detection port that has migrated in the path in the subject; (c) comparing the detected signal with the introduced signal and determining therefrom the phase shift of said detected signal from said introduced signal, said phase shift being indicative of said scattering and absorptive properties of the subject; and (d) examining said subject by employing said phase shift.

Claim 37

A spectroscopic method of examination of a subject, the subject lying between an optical input port and an optical detection port of a spectroscopic system, the optical pathlength of photons migrating between said ports being determined by the scattering and absorptive properties of the particular subject, the method comprising the steps of: (a) introducing into the subject at the input port at least one electromagnetic signal of selected wavelength, the signal having been modulated by a carrier waveform of frequency that enables determination of said pathlength; (b) detecting the signal at the detection port that has migrated in the path in the subject; (c) comparing the detected signal with the introduced signal and determining therefrom the phase shift of said detected signal from said introduced signal, said phase shift being indicative of said scattering and absorptive properties of the subject; and (d) examining said subject by employing said phase shift.

Claim 38

The method of claim 32 wherein said step of employing said phase shift comprises: (a) calculating, based on said phase shift, said optical pathlength of said signal between said optical input port and said optical detection port; and (b) determining a property of said subject based upon said pathlength.

Claim 39

The method of claim 32 or 33 wherein at least two electromagnetic signals of different selected wavelengths, modulated at said frequency, are introduced into the subject, and said step of examining said subject by employing said phase shift being performed utilizing each of said wavelengths.

Claim 40

The method of claim 34 wherein said introducing and detecting steps comprise: (a) generating a first carrier waveform at a first frequency on the order of 10 8 Hz using first oscillator means; (b) generating a second carrier waveform at a second frequency using second oscillator means, said second frequency being offset from said first frequency; (c) generating two electromagnetic signals modulated by said first carrier waveform, said two electromagnetic signals having different selected wavelengths sensitive to hemoglobin oxygenation; (d) coupling said two electromagnetic signals of said selected wavelengths to the subject; and (e) detecting two altered phase-shifted waveforms corresponding to said two electromagnetic signals of said selected wavelengths, said altered signals having been phase-shifted during migration in the subject.

Claim 41

The method of claim 33 wherein said wavelength is selected from the region of about 750 nm to 850 nm.

Claim 42

The method of claim 32, 33 or 36 wherein said subject comprises tissue of a living being, said frequency of said carrier waveform is of the order of 10 8 Hz, and said method comprising in vivo examination of said tissue.